Ultra-Sensitive Fluorimetric Method for the First Estimation of Vonoprazan in Real Human Plasma and Content Uniformity Test

Vonoprazan (VON) has been approved recently via US-FDA in 2015 as the first in class of potassium competitive acid blocker group. VON is used for management of GIT ulcer, reflux esophagitis and for eradication of Helicobacter pylori. So, the first spectrofluorimetric method was developed for estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraya, Roshdy E., Hassan, Yasser F., Eltukhi, Walid E., Salman, Baher I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402479/
https://www.ncbi.nlm.nih.gov/pubmed/35670919
http://dx.doi.org/10.1007/s10895-022-02979-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402479/
https://www.ncbi.nlm.nih.gov/pubmed/35670919
http://dx.doi.org/10.1007/s10895-022-02979-2

Ejemplares similares